Výsledky vyhledávání - "José Angel, Arranz Arija"

Efectividad de la talidomida y la dexametasona en el tratamiento del mieloma múltiple resistente al tratamiento: estudio retrospectivo de 36 casos consecutivos

Autor: Víctor Manuel Díaz Muñoz de la Espada, Parham Khosravi Shahi, Sara García, José Rafael Carrión Galindo, Gumersindo Pérez Manga, José Angel Arranz Arija, Pilar Sabin Domínguez

Publikováno v: Medicina Clínica. 128:121-124

Fundamento y objetivo El mieloma multiple (MM) es una neoplasia de celulas plasmaticas que se caracteriza por la presencia de una proteina monoclonal en suero u orina. La talidomida es un farmaco eficaz en el tratamiento de segunda linea de esta enfe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d656777b06f71ce05da1bb69d6d56855
https://doi.org/10.1157/13098017

Zobrazit plný text záznamu

[Treatment of the patient with castration-resistant biochemical progression of prostate cancer]

Autor: José Angel Arranz, Arija, Rafael González, Beca, Cristina López, López, Pilar Sabin, Domínguez, Alicia Soria, Lovelle, Yolanda Jerez, Gilarranz

Publikováno v: Archivos espanoles de urologia. 65(1)

Castration resistant prostatic carcinoma (CRPC) is defined as tumor progression despite an effective castration (serum testosterone levels50 ng/dL). Biochemical progression requires at least two successive increases from the previous lowest value of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::db366b5cab1f932723f33799ec5a2121
https://pubmed.ncbi.nlm.nih.gov/22318189

Zobrazit plný text záznamu

[Effectivity of thalidomide and dexamethasone for the treatment of refractory multiple myeloma: a retrospective study of 36 consecutive cases]

Autor: Parham, Khosravi Shahi, Víctor Manuel, Díaz Muñoz de la Espada, Pilar, Sabin Domínguez, Sara, Encinas García, José Angel, Arranz Arija, José Rafael, Carrión Galindo, Gumersindo, Pérez Manga

Publikováno v: Medicina clinica. 128(4)

Multiple myeloma (MM) is a plasm-cell neoplasm characterized by a monoclonal protein in the serum or urine. Thalidomide is effective as second line treatment.We performed a retrospective study of 36 consecutive patients with refractory MM treated wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f16868558cfb74804e7a142da4c9d49e
https://pubmed.ncbi.nlm.nih.gov/17288931

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání